THE POTENT AND SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST A-77636 INCREASES CORTICAL AND HIPPOCAMPAL ACETYLCHOLINE-RELEASE IN THE RAT

被引:36
作者
ACQUAS, E [1 ]
DAY, JC [1 ]
FIBIGER, HC [1 ]
机构
[1] UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,DIV NEUROL SCI,VANCOUVER V6T 1Z3,BC,CANADA
基金
英国医学研究理事会;
关键词
ACETYLCHOLINE; FRONTAL CORTEX; HIPPOCAMPUS; MICRODIALYSIS; DOPAMINE D-1 RECEPTOR;
D O I
10.1016/0014-2999(94)90013-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of systemic administration of the full dopamine D-1 receptor agonist A-77636 on acetylcholine release in rat frontal cortex and hippocampus were studied using in vivo microdialysis. Administration of A-77636 (4 mu mol/kg s.c.) greatly (> 230%) increased both cortical and hippocampal acetylcholine release for more than 3 h; at a lower dose (1 mu mol/kg s.c.) A-77636 significantly stimulated cortical but not hippocampal acetylcholine release. The effect of the;higher dose of A-77636 on cortical acetylcholine release was blocked by the dopamine D-1 receptor antagonist SCH 23390 (300 mu g/kg s.c.). These results confirm that stimulation of dopamine D-1 receptors facilitates cortical and hippocampal acetylcholine release in vivo, and indicate that these two structures are differentially sensitive to this effect. They also raise the possibility that dopamine D-1 receptor agonists may be useful in the treatment of cortical and hippocampal acetylcholine deficit-related syndromes.
引用
收藏
页码:85 / 87
页数:3
相关论文
共 11 条
[1]   EFFECTS OF REPEATED DOPAMINE-D(1) RECEPTOR STIMULATION ON ROTATION AND C-FOS EXPRESSION [J].
ASIN, KE ;
WIRTSHAFTER, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) :167-168
[2]  
BARTUS RT, 1987, PSYCHOPHARMACOLOGY 3, P219
[3]   CHOLINERGIC ACTIVITY IN THE RAT HIPPOCAMPUS, CORTEX AND STRIATUM CORRELATES WITH LOCOMOTOR-ACTIVITY - AN INVIVO MICRODIALYSIS STUDY [J].
DAY, J ;
DAMSMA, G ;
FIBIGER, HC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 38 (04) :723-729
[4]   DOPAMINERGIC REGULATION OF CORTICAL ACETYLCHOLINE-RELEASE - EFFECTS OF DOPAMINE RECEPTOR AGONISTS [J].
DAY, J ;
FIBIGER, HC .
NEUROSCIENCE, 1993, 54 (03) :643-648
[5]  
DAY JC, 1994, IN PRESS J NEUROCHEM
[6]   CHOLINERGIC MECHANISMS IN LEARNING, MEMORY AND DEMENTIA - A REVIEW OF RECENT-EVIDENCE [J].
FIBIGER, HC .
TRENDS IN NEUROSCIENCES, 1991, 14 (06) :220-223
[7]   A-77636 - A POTENT AND SELECTIVE DOPAMINE-D1 RECEPTOR AGONIST WITH ANTIPARKINSONIAN ACTIVITY IN MARMOSETS [J].
KEBABIAN, JW ;
BRITTON, DR ;
DENINNO, MP ;
PERNER, R ;
SMITH, L ;
JENNER, P ;
SCHOENLEBER, R ;
WILLIAMS, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (2-3) :203-209
[8]  
MARKSTEIN R, 1988, PROGR CATECHOLAMIN B, P59
[9]   FURTHER ANALYSIS OF THE COGNITIVE EFFECTS OF TETRAHYDROAMINOACRIDINE (THA) IN ALZHEIMERS-DISEASE - ASSESSMENT OF ATTENTIONAL AND MNEMONIC FUNCTION USING CANTAB [J].
SAHAKIAN, BJ ;
OWEN, AM ;
MORANT, NJ ;
EAGGER, SA ;
BODDINGTON, S ;
CRAYTON, L ;
CROCKFORD, HA ;
CROOKS, M ;
HILL, K ;
LEVY, R .
PSYCHOPHARMACOLOGY, 1993, 110 (04) :395-401
[10]   DISTRIBUTION AND ORGANIZATION OF CHOLINERGIC NEURONS IN THE RAT FOREBRAIN DEMOSTRATED BY COMPUTER-AIDED DATA ACQUISITION AND 3-DIMENSIONAL RECONSTRUCTION [J].
SCHWABER, JS ;
ROGERS, WT ;
SATOH, K ;
FIBIGER, HC .
JOURNAL OF COMPARATIVE NEUROLOGY, 1987, 263 (03) :309-325